Find policies, billing codes, payers, states, and providers
CPT 92522: Speech Sound Production Evaluation
CPT code 92522 represents a focused speech–language pathology evaluation of speech sound production, assessing articulation, phonological patterns, and the structure and function of the jaw, lips, and tongue. This code is used nationally for diagnostic assessments that identify causes of incorrect pronunciation and plan targeted interventions. The code matters as speech sound disorders are common across pediatrics and adults with neurologic or structural impairments, driving demand for diagnostic SLP services in outpatient and rehabilitative settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find an overview of how 92522 is used clinically, its position relative to related SLP codes, typical sites of service, and the primary diagnoses that commonly trigger use of the code. The publication includes benchmark information and payer coverage context to inform billing, coding, and operational workflows, along with clinical context that clarifies when a focused speech sound production evaluation is appropriate versus broader language or voice assessments.
The content is intended for clinicians, billing professionals, and policy analysts who need concise guidance on the clinical purpose of 92522, payer coverage landscape, and its relationship to adjacent SLP procedure codes.
Customize your policy alerts
Sign up for cpt 92522 policy alerts
Get alerted when payer policies referencing 92522 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 92522 describes an evaluation by a speech–language pathologist (SLP) focused on speech sound production, including assessment of incorrect pronunciation and error patterns. The evaluation includes examination of the jaw, lips, and tongue for proper structure and function to identify articulation, phonological, or motor-speech problems.
Service type: Speech‑language pathology evaluation (speech sound production assessment)
Typical site of service: Outpatient clinic, office, or specialty rehabilitation setting where SLPs provide one‑on‑one diagnostic assessments
National Reimbursement Benchmarks
Nationally, Medicare averages $115.60 for CPT 92522 while BUCA’s mean commercial rate is $210.80, so BUCA sits about $95.20 higher than Medicare on average, reflecting materially higher commercial reimbursement versus the federal program. Blue Cross Blue Shield and Aetna show higher mean levels than Medicare as well, while Cigna and UnitedHealth Group fall between Medicare and BUCA.
Dispersion (P75 minus P25) highlights where rates are most and least variable: Blue Cross Blue Shield is widest with a spread of $116.60 ($325.60 - $194.00), followed by UnitedHealth Group at $95.40 ($189.30 - $98.59) and Cigna at $109.20 ($216.90 - $107.70). Aetna is the tightest among listed commercial payers with a spread of $36.20 ($113.80 - $76.00). Medicare’s interquartile spread is $8 ($118 - $110).